111 related articles for article (PubMed ID: 8993486)
1. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.
Small GW; Komo S; La Rue A; Saxena S; Phelps ME; Mazziotta JC; Saunders AM; Haines JL; Pericak-Vance MA; Roses AD
Ann N Y Acad Sci; 1996 Dec; 802():70-8. PubMed ID: 8993486
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.
Small GW
J Clin Psychiatry; 1996; 57 Suppl 14():9-13. PubMed ID: 9024331
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL
Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010
[TBL] [Abstract][Full Text] [Related]
5. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
Hyman BT; Gomez-Isla T; Rebeck GW; Briggs M; Chung H; West HL; Greenberg S; Mui S; Nichols S; Wallace R; Growdon JH
Ann N Y Acad Sci; 1996 Dec; 802():1-5. PubMed ID: 8993478
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.
Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC
Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872
[TBL] [Abstract][Full Text] [Related]
10. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
11. Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.
Small GW
Adv Drug Deliv Rev; 2002 Dec; 54(12):1561-6. PubMed ID: 12453673
[TBL] [Abstract][Full Text] [Related]
12. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.
Tanaka S; Kawamata J; Shimohama S; Akaki H; Akiguchi I; Kimura J; Ueda K
Dement Geriatr Cogn Disord; 1998; 9(2):90-8. PubMed ID: 9524800
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.
Hashimoto M; Yasuda M; Tanimukai S; Matsui M; Hirono N; Kazui H; Mori E
Neurology; 2001 Oct; 57(8):1461-6. PubMed ID: 11673590
[TBL] [Abstract][Full Text] [Related]
14. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
[TBL] [Abstract][Full Text] [Related]
16. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
17. Brain-imaging surrogate markers for detection and prevention of age-related memory loss.
Small GW
J Mol Neurosci; 2002; 19(1-2):17-21. PubMed ID: 12212776
[TBL] [Abstract][Full Text] [Related]
18. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
[TBL] [Abstract][Full Text] [Related]
19. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.
Small GW; Ercoli LM; Silverman DH; Huang SC; Komo S; Bookheimer SY; Lavretsky H; Miller K; Siddarth P; Rasgon NL; Mazziotta JC; Saxena S; Wu HM; Mega MS; Cummings JL; Saunders AM; Pericak-Vance MA; Roses AD; Barrio JR; Phelps ME
Proc Natl Acad Sci U S A; 2000 May; 97(11):6037-42. PubMed ID: 10811879
[TBL] [Abstract][Full Text] [Related]
20. Early detection of Alzheimer's disease using neuroimaging.
Mosconi L; Brys M; Glodzik-Sobanska L; De Santi S; Rusinek H; de Leon MJ
Exp Gerontol; 2007; 42(1-2):129-38. PubMed ID: 16839732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
